MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis
- 18 May 2010
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 72 (6) , 744-751
Abstract
Purpose Massive macronodular adrenocortical disease (MMAD) may be caused by aberrant microRNA expression. To determine the microRNA profile in MMAD and identify putative microRNA–gene target pairs involved in adrenal tumourigenesis. Experimental design We performed microRNA microarray analysis in 10 patients with ACTH‐independent Cushing syndrome caused by MMAD (ages 39–60 years) and four normal adrenal cortex samples were used as controls. Microarray data were validated by real‐time polymerase chain reaction (qRT‐PCR). Identification of potential microRNA–gene target pairs implicated in MMAD pathogenesis has been performed by integrating our microRNA data with previously obtained cDNA microarray data. Experimental validation of specific microRNA gene targets was performed by transfection experiments and luciferase assay. Results A total of 37 microRNAs were differentially expressed between MMAD and normal tissues; 16 microRNAs were down‐regulated, including miR‐200b and miR‐203, whereas 21 microRNAs were up‐regulated, miR‐210 and miR‐484 among them. Comparison of microRNA data with different clinicopathological parameters revealed miR‐130a and miR‐382 as putative diagnostic MMAD markers. Interestingly, we detected miR‐200b targeting directly Matrin 3 (MATR3) expression in an adrenocortical cancer cell line (H295R). Conclusions MicroRNAs appear to have distinct regulatory effects in MMAD, including an association with clinical presentation and severity of the disease, expressed by the degree of hypercortisolism. This is the first investigation of microRNAs in MMAD, a disease with complex pathogenesis; the data indicate that specific microRNAs such as miR‐200b may play a significant role in MMAD formation and/or progression.Keywords
This publication has 34 references indexed in Scilit:
- Distinct microRNA expression profiles in acute myeloid leukemia with common translocationsProceedings of the National Academy of Sciences, 2008
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate CancerCancer Research, 2008
- Genetic variants of miRNA sequences and non–small cell lung cancer survivalJournal of Clinical Investigation, 2008
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene ExpressionCancer Cell, 2008
- Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5Blood, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- Activation of NMDA receptors induces protein kinase A‐mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA‐induced neuronal deathJournal of Neurochemistry, 2005
- Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's SyndromeEndocrine Reviews, 2001